A Phase 1b/2 Study of PF-06747775 As Monotherapy or in Combination with Palbociclib in Patients with Epidermal Growth Factor Receptor Mutant Advanced Non-Small Cell Lung Cancer.
Expert Opinion on Investigational Drugs（2022）
关键词
(5-8),advanced non-small cell lung cancer,epidermal growth factor receptor,PF-06747775,phase 1,2 study,tyrosine kinase inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要